Navigation Links
US FDA Approves 30-Minute Onset of Action for Focalin(R) XR, Bringing Potential Benefits to ADHD Patients During Early Morning Period
Date:11/12/2008

Data indicate Focalin XR provides rapid and significant improvements in attention, behavior and academic productivity at 30 minutes post-dose Early onset of effect may help with school preparation in the morning as well as potentially improving academic productivity for children with ADHD

EAST HANOVER, N.J., Nov. 12 /PRNewswire/ -- The US Food and Drug Administration (FDA) has approved a 30-minute onset of action for Focalin(R) XR (dexmethylphenidate HCl) extended-release capsules for the treatment of Attention Deficit/Hyperactivity Disorder (ADHD), bringing potential benefits for young patients and their families during the important morning period when they are preparing for school.

"The morning is a critical time for families," said Alice Mao, MD, Associate Professor of Psychiatry at the Baylor College of Medicine. "The early onset of Focalin XR provides symptom control which may help families and children living with ADHD get through their morning routine."

The new labeling is based on clinical study data. The most recent study, involving 86 children with ADHD between the ages of six and 12, showed that Focalin XR provided significant improvements at 30 minutes post-dose compared to placebo in measures of attention, deportment, and academic productivity.

ADHD affects approximately three to six percent of children in the United States, and its symptoms - inattention, hyperactivity and impulsivity - can significantly impact a child's ability to focus and behave in school.

A 2007 Harris survey of 1,001 caregivers of young ADHD patients revealed that caregivers were significantly more likely to report that their child's or adolescent's behavior was negatively affected in the morning compared to other periods through the day in 12 out of 16 common behaviors. These negative behaviors included lack of concentration, messiness, interrupting others, failure to complete tasks and speaking out of turn.

"The 30-minute ons
'/>"/>

SOURCE Novartis Pharmaceuticals Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. FDA Approves New Indication for Hospiras Precedex (Dexmedetomidine HCL) Injection
2. Triple-S Management Corporation Reports Third Quarter 2008 Results; Board Approves Share Repurchase Authorization of up to $40 Million
3. Kaiser Permanente Approves $12 Million in Community Benefit Grants in Third Quarter of 2008
4. Congress Sets New Course for Lung Cancer Research; Approves $20 Million for New Defense Department Program
5. FDA Approves Nasacort AQ(R) Nasal Spray for Children Aged 2-5 years old
6. ClearWay Minnesota(SM) Board Approves New Officers
7. FDA approves first drug for Huntingtons disease
8. The California Board of Registered Nursing Approves Affiliations for Nursing Program in Glendale, California
9. Kaiser Permanente Approves $22 Million in Community Benefit Grants in Second Quarter of 2008
10. Hillenbrand, Inc. Board of Directors Approves $100M Share Repurchase Program
11. Edwards Lifesciences Board Approves New $250 Million Share Repurchase Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... 2015 This year, Mental Health America ... and encouraging those affected to seek assistance before a crisis ... one in five children, ages 13 to 18, are ... of all cases of mental illness within one's lifetime will ... essential to seek help before reaching a critical stage — ...
(Date:5/27/2015)... (PRWEB) May 27, 2015 Kudolife ... its much-anticipated Apple Watch release available at ... health-conscious users to track their calories and activities with ... background to identify activity type for accurate tracking. , ... with the sought-after Apple Watch, which will allow users ...
(Date:5/27/2015)... 2015 Net Pistol proudly welcomes two ... clients: , The Mobility Van Store of Lakeland, Florida, ... in the mobility industry. They have a team of ... or pre-owned wheelchair-accessible van, truck or car. Additionally, they ... lift chairs, three and four-wheel scooters, and manual wheelchairs. ...
(Date:5/27/2015)... New York (PRWEB) May 27, 2015 ... Spa will now be offering Eco-fin Hand Treatments ... Eco-fin treatment is a paraffin wax alternative. It is ... with 100% natural plant-based emollients and pure essential oils. ... , "We have used Eco-fin treatments for our ...
(Date:5/27/2015)... 2015 The Academy of Oncology Nurse ... Regional Meeting in Seattle. This intimate gathering, held between ... navigation and oncology professionals from west of the Mississippi ... “One of the most important things that an organization ... needs and do the best it can to fulfill ...
Breaking Medicine News(10 mins):Health News:The Glenholme School Observes Mental Health Awareness Month 2Health News:The Glenholme School Observes Mental Health Awareness Month 3Health News:Kudolife Launches into Apple Watch App Market with Newest Release 2Health News:Kudolife Launches into Apple Watch App Market with Newest Release 3Health News:Net Pistol Continues Success Serving Mobility Dealers 2Health News:Long Island's Massage and Spa Of Commack Announces A Change To Their Spa Party Menu Of Services 2Health News:Long Island's Massage and Spa Of Commack Announces A Change To Their Spa Party Menu Of Services 3Health News:AONN+’s West Coast Regional Meeting Brings Oncology Nurse and Patient Navigators Together for Two Days of Education and Networking 2Health News:AONN+’s West Coast Regional Meeting Brings Oncology Nurse and Patient Navigators Together for Two Days of Education and Networking 3
... Wake Forest University School of Medicine has reported in ... to the aorta which may occur due to bypass ... heart which may lead to cognitive loss and the ... to the aorta reduces development of cognitive defects. ...
... wristwatch invented by South Africa's Gervan Lubbe which can detect ... hazard. They have warned that the device may contribute towards ... also expressed doubts if the watch can really perform functions ... a potential public health threat as opposed to a boon ...
... four Marlboro smokers for hi-tech screenings aimed at the early detection ... pay for spiral CT scans which is estimated at ?300. //If ... save several thousand lives as a result of early detection. The ... smoking. ,A class action status is sought by ...
... International study conducted by the University of New South ... the HIV treatment can be life threatening and resulted ... because //they identified that the patients who took a ... progression of the disease, compared with those who took ...
... teenage smokers in Alberta in 2005, when in comparison to 2004. ... are being blamed for this by anti-smoking campaigners. The young adult ... the Alberta Alcohol and Drug Abuse Commission for this state of ... of Alberta who belong to the age group of 15 years ...
... the Health Minister on the prescription issue. Under this nurses ... move has been widely criticized, but the BMA's GP committee ... statement of the Health Minister on the introduction of nurse ... who should be able to spend more time with those ...
Cached Medicine News:Health News:Breaks In The HIV Treatment Resulted In Devastating Results. 2
(Date:5/26/2015)... May 26, 2015  AbbVie (NYSE: ABBV ... GIFT-I study of its investigational, all-oral, interferon (IFN)- ... ombitasvir/paritaprevir/ritonavir at the Annual Meeting of the Japan ... . 1 GIFT-I evaluated genotype 1b ... patients, with and without cirrhosis, who were either ...
(Date:5/26/2015)... -- XRpro Sciences, Inc., a provider of a unique platform for ... and ion channel assays for the pharmaceutical industry, announced today ... MicroCap Conference on Thursday, May 28, 2015 in ... Hotel. The Company,s presentation by Richie Cunningham ... to begin at 1:30 p.m ET. Click here to view ...
(Date:5/26/2015)... PITTSBURGH , May 26, 2015 /PRNewswire/ ... pharmaceutical company, today announced that Mylan CEO Heather ... Decisions Conference, Friday, May 29, 2015 at 9 a.m. ... live webcast of the presentation via the investor relations ... archived version will also be available following the live ...
Breaking Medicine Technology:AbbVie Presents New Data for its Investigational Hepatitis C Treatment in Japanese Patients With and Without Cirrhosis 2AbbVie Presents New Data for its Investigational Hepatitis C Treatment in Japanese Patients With and Without Cirrhosis 3AbbVie Presents New Data for its Investigational Hepatitis C Treatment in Japanese Patients With and Without Cirrhosis 4AbbVie Presents New Data for its Investigational Hepatitis C Treatment in Japanese Patients With and Without Cirrhosis 5AbbVie Presents New Data for its Investigational Hepatitis C Treatment in Japanese Patients With and Without Cirrhosis 6XRpro Sciences, Inc. To Present at 2015 Marcum MicroCap Conference 2
... (Nasdaq: BIOD ) today reported financial results for the ... Year 2011 Financial Results Biodel reported a net loss ... or $0.20 per share, compared to a net loss of $11.1 ... prior year. Research and development expenses were $5.5 ...
... CFN ), a leading, global medical technology company, ... Dec. 31, 2010. "Our strong second quarter results ... Infection Prevention businesses, and a benefit from a lower tax ... had announced in November 2010 his plans to retire. On ...
Cached Medicine Technology:Biodel Reports First Quarter Fiscal Year 2011 Financial Results 2Biodel Reports First Quarter Fiscal Year 2011 Financial Results 3Biodel Reports First Quarter Fiscal Year 2011 Financial Results 4Biodel Reports First Quarter Fiscal Year 2011 Financial Results 5Biodel Reports First Quarter Fiscal Year 2011 Financial Results 6CareFusion Reports Second Quarter Fiscal 2011 Results 2CareFusion Reports Second Quarter Fiscal 2011 Results 3CareFusion Reports Second Quarter Fiscal 2011 Results 4CareFusion Reports Second Quarter Fiscal 2011 Results 5CareFusion Reports Second Quarter Fiscal 2011 Results 6CareFusion Reports Second Quarter Fiscal 2011 Results 7CareFusion Reports Second Quarter Fiscal 2011 Results 8CareFusion Reports Second Quarter Fiscal 2011 Results 9CareFusion Reports Second Quarter Fiscal 2011 Results 10CareFusion Reports Second Quarter Fiscal 2011 Results 11CareFusion Reports Second Quarter Fiscal 2011 Results 12CareFusion Reports Second Quarter Fiscal 2011 Results 13CareFusion Reports Second Quarter Fiscal 2011 Results 14CareFusion Reports Second Quarter Fiscal 2011 Results 15
Bruns (Volkmann) bone curette, with Novotex plastic handle (autoclavable in autoclave up to 143C by 3 bar), 9, oval....
MRI curette, 8.5" overall length....
15" overall length, 5" handle....
10" overall length, 5" handle....
Medicine Products: